TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memoryIker Ausejo‐Mauleon, Marta M. Alonso, Viveka Nand Yadav et al.|Cancer Cell|2023Cited by 107
T2-FLAIR Mismatch: An Imaging Biomarker for Children’s<i>MYB/MYBL1</i>–Altered Diffuse Astrocytoma or Angiocentric GliomaEmiel A. van Maren, Maarten H. Lequin, Jan Willem Dankbaar et al.|American Journal of Neuroradiology|2024Cited by 12
Sex-related incidence and survival differences in pediatric high-grade glioma subtypes: A population-based cohort studyRaoull Hoogendijk, Dannis G. van Vuurden, Jasper van der Lugt et al.|iScience|2023Cited by 9
Do we need B7-H3 immunohistochemistry for the inclusion of children with high-grade central nervous system tumors in clinical trials targeting B7-H3?Mariëtte E.G. Kranendonk, Sabine Plasschaert, Raoull Hoogendijk et al.|Neuro-Oncology|2025Cited by 6
Long-term survival and cure fraction estimates for paediatric central nervous system tumours in 31 European countries (EUROCARE-6): a population-based studyRaoull Hoogendijk, Riccardo Capocaccia, Jasper van der Lugt et al.|The Lancet Oncology|2025Cited by 5